Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Novel anti-hepatitis C virus (HCV) agents discovered at Enanta

March 4, 2005

New opioid receptor antagonists for gastrointestinal dysfunction disclosed by Adolor

March 3, 2005

A novel PAR2 agonist induces gastric mucosal cytoprotection

March 3, 2005

AstraZeneca imparts the synthesis of three series of H+/K+-ATPase inhibitors

March 2, 2005

Advitech and the CHULRC to test XP-828L for inflammatory bowel diseases

March 1, 2005

Pegasys receives FDA approval for HIV-HCV coinfected patients

Feb. 28, 2005

Promising results reported for the purgative INKP-102 in colonoscopy patients

Feb. 28, 2005

Pegasys approved for hepatitis B in Europe

Feb. 25, 2005

Tripep reports on ChronVac developments

Feb. 25, 2005

Entecavir reported effective against recurrent HBV viremia in HIV/HBV coinfection

Feb. 24, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...